(Q33604209)

28 July 2017

1 reference

title

Tolterodine, a new antimuscarinic drug for treatment of bladder overactivity (English)

1 reference

28 July 2017

Guay DR

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

19

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

267-280

1 reference

Definition of overactive bladder and epidemiology of urinary incontinence

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.267.30943

Economic costs of urinary incontinence in 1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.267.30943

The overactive bladder: pharmacologic basis of drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.267.30943

Urodynamic and other effects of tolterodine: a novel antimuscarinic drug for the treatment of detrusor overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.267.30943

Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.267.30943

Tolterodine--a new bladder-selective antimuscarinic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.267.30943

Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.267.30943

Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.267.30943

Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.4.267.30943

10.1592/PHCO.19.4.267.30943

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference